Bionexus Gene Lab Corp (BGLC)

$2.11 +0.12 (6.03%)
Market Cap 5.56M
Revenue (ttm) 9.51M
Net Income (ttm) -1.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -16.82%
Debt to Equity Ratio 0.00
Volume 5,056
Avg Vol 103,140
Day's Range N/A - N/A
Shares Out 2.36M
Stochastic %K 1%
Beta 5.27
Analysts Strong Buy
Price Target N/A

Company Profile

BioNexus Gene Lab Corp., through its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SH...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 60 1 307 241 6898
Address:
Menara UOA Bangsar, Unit A-28-7, Level 28, Tower A No.5 Jln Bangsar Utama 1, Kuala Lumpur, Malaysia
trader87
trader87 Feb. 6 at 2:04 PM
$BTOG $FTFT $SQFT $BGLC who will make it first? gl folks!
0 · Reply
TheBigSauce
TheBigSauce Feb. 6 at 11:07 AM
$NWGL 🇨🇳 Another oversold China play expecting a bounce. I’m a buyer. Also moved massive $TIRX prifits here. I see several joined me as well $LGHL and $HUDI two others to keep watch and $BGLC too. Let’s see if today’s market rebounds
0 · Reply
blakely90
blakely90 Feb. 5 at 8:47 PM
AMST stock is disrupting the healthcare sector using AI. No debt + micro float with a low dilution risk. 5+ coming and this should be a $20 stock. News coming any day! Bottomed out under $2 is a steal. The CEO loaded $1M worth of shares at $3 and never has sold! Insiders will load up again here at lows! wl: $ICG $BGLC $VSA $AUST $ASBP
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 4 at 8:18 PM
$BGLC RSI: 18.78, MACD: -0.4007 Vol: 0.53, MA20: 3.24, MA50: 3.82 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TheBigSauce
TheBigSauce Feb. 4 at 6:50 PM
$CHR 💪 Let’s keep the rocket streak alive!! 🇨🇳 🚀🚀. I want $2++ $TIRX Amazing run. Moving profits to CHR now. China has been good with $LGHL $AURE $BGLC all banked
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 8:22 AM
$BGLC Excellent article that nails exactly where BGLC stands right now. So if you want to update your BGLC knowledge or get acquainted with BGLC, this is a must read. https://everyticker.com/quote/BGLC/analysis/bglc-s-high-risk-pivot-can-a-micro-cap-diagnostics-player-outrun-its-scale-problem-in-southeast-asia-nasdaq-bglc
0 · Reply
DaBullRunner
DaBullRunner Feb. 3 at 10:20 PM
$BATL told you about this one EARLY👇💰💰💰 🚨GCTS🚨will be my BIGGEST pay day of the year Remember this post $WTO $BGLC $ELPW $LIMN what a solid day 🙏
1 · Reply
drweinerdog1
drweinerdog1 Feb. 2 at 8:00 PM
$BGLC any hope here?
0 · Reply
AZOZ
AZOZ Jan. 30 at 1:57 PM
$BGLC Oversold swing idea 💡
0 · Reply
drweinerdog1
drweinerdog1 Jan. 29 at 8:35 PM
$BGLC what is going on here, dilution?
0 · Reply
Latest News on BGLC
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market

Jan 28, 2026, 9:00 AM EST - 9 days ago

BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

Dec 3, 2025, 8:45 AM EST - 2 months ago

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

Dec 2, 2025, 8:05 AM EST - 2 months ago

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

Dec 1, 2025, 8:00 AM EST - 2 months ago

BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

Nov 12, 2025, 8:00 AM EST - 3 months ago

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

Nov 10, 2025, 8:00 AM EST - 3 months ago

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

Oct 20, 2025, 8:00 AM EDT - 3 months ago

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology

Jul 30, 2025, 8:00 AM EDT - 6 months ago

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

Apr 30, 2025, 11:25 AM EDT - 10 months ago

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

Apr 15, 2025, 11:00 AM EDT - 10 months ago

BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

Mar 7, 2025, 11:00 AM EST - 1 year ago

BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

Mar 5, 2025, 11:00 AM EST - 1 year ago

BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

Sep 25, 2024, 11:31 AM EDT - 1 year ago

BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

Sep 13, 2024, 12:05 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

Sep 12, 2024, 1:23 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

Sep 11, 2024, 11:05 AM EDT - 1 year ago

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

Aug 27, 2024, 11:35 AM EDT - 1 year ago

BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

Aug 26, 2024, 12:15 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

Apr 18, 2024, 2:52 PM EDT - 1 year ago

BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

Jul 24, 2023, 11:30 AM EDT - 2 years ago

BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

Jul 20, 2023, 1:29 PM EDT - 2 years ago

BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

trader87
trader87 Feb. 6 at 2:04 PM
$BTOG $FTFT $SQFT $BGLC who will make it first? gl folks!
0 · Reply
TheBigSauce
TheBigSauce Feb. 6 at 11:07 AM
$NWGL 🇨🇳 Another oversold China play expecting a bounce. I’m a buyer. Also moved massive $TIRX prifits here. I see several joined me as well $LGHL and $HUDI two others to keep watch and $BGLC too. Let’s see if today’s market rebounds
0 · Reply
blakely90
blakely90 Feb. 5 at 8:47 PM
AMST stock is disrupting the healthcare sector using AI. No debt + micro float with a low dilution risk. 5+ coming and this should be a $20 stock. News coming any day! Bottomed out under $2 is a steal. The CEO loaded $1M worth of shares at $3 and never has sold! Insiders will load up again here at lows! wl: $ICG $BGLC $VSA $AUST $ASBP
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 4 at 8:18 PM
$BGLC RSI: 18.78, MACD: -0.4007 Vol: 0.53, MA20: 3.24, MA50: 3.82 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
TheBigSauce
TheBigSauce Feb. 4 at 6:50 PM
$CHR 💪 Let’s keep the rocket streak alive!! 🇨🇳 🚀🚀. I want $2++ $TIRX Amazing run. Moving profits to CHR now. China has been good with $LGHL $AURE $BGLC all banked
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 8:22 AM
$BGLC Excellent article that nails exactly where BGLC stands right now. So if you want to update your BGLC knowledge or get acquainted with BGLC, this is a must read. https://everyticker.com/quote/BGLC/analysis/bglc-s-high-risk-pivot-can-a-micro-cap-diagnostics-player-outrun-its-scale-problem-in-southeast-asia-nasdaq-bglc
0 · Reply
DaBullRunner
DaBullRunner Feb. 3 at 10:20 PM
$BATL told you about this one EARLY👇💰💰💰 🚨GCTS🚨will be my BIGGEST pay day of the year Remember this post $WTO $BGLC $ELPW $LIMN what a solid day 🙏
1 · Reply
drweinerdog1
drweinerdog1 Feb. 2 at 8:00 PM
$BGLC any hope here?
0 · Reply
AZOZ
AZOZ Jan. 30 at 1:57 PM
$BGLC Oversold swing idea 💡
0 · Reply
drweinerdog1
drweinerdog1 Jan. 29 at 8:35 PM
$BGLC what is going on here, dilution?
0 · Reply
TheBigSauce
TheBigSauce Jan. 28 at 6:20 PM
$AURE $BGLC $LGHL $TIRX TIRX 🔥🚀Paid to be early, right?! $LBGJ 👀Next up! We buy it cheap.
0 · Reply
TheBigSauce
TheBigSauce Jan. 28 at 2:06 PM
$AURE $BGLC $LGHL $TIRX TIRX 🚀Pays to be early! Big bank! $LBGJ looks ready for $2 launch. It’s next up imo
0 · Reply
Stock_Catcher
Stock_Catcher Jan. 28 at 2:01 PM
$BGLC BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
0 · Reply
TheBigSauce
TheBigSauce Jan. 28 at 12:45 PM
$AURE $BGLC $LGHL $TIRX TIRX 🚀🚀Gave it to you early. Hope you’re banking with me
0 · Reply
TheBigSauce
TheBigSauce Jan. 28 at 12:39 PM
$AURE $BGLC $LGHL $TIRX TIRX 🚀🚀🚀 I bought the fear and feel really good now
0 · Reply
TheBigSauce
TheBigSauce Jan. 28 at 11:59 AM
$TIRX Seen this China game many times. Now let’s get ready for the magic pump. Reminds me a lot like $AURE $LGHL $BGLC and several others that had a double.
0 · Reply
Dragon3505
Dragon3505 Jan. 27 at 6:09 PM
$BGLC This low float name is in oversold level. Nice chart for a breaout. In July 2025 went from 2.9 to 15.7 in a single day. As soon as it get volume or PR it will go parabolic. Only 25k share for short.Lets squezee them! $GITS $XHLD $NUWE
0 · Reply
boffa
boffa Jan. 16 at 7:35 PM
$BGLC Honest question for holders: why hold long-term when there’s a $500M equity facility over 36 months? Is the thesis that revenue growth will outpace dilution, or are people trading spikes only? Trying to understand the bull case beyond momentum.
2 · Reply
Sulty
Sulty Jan. 7 at 3:26 PM
$BGLC longs! 1k move this up 4% . Can you image
0 · Reply
Sulty
Sulty Dec. 31 at 2:40 PM
$BGLC longs! We touch 3.60-80 we rip! It will happen fast!
0 · Reply
GrayMarketG
GrayMarketG Dec. 25 at 1:19 PM
$BGLC Expectations are shifting from future promises toward demonstrated capability. Commercial adoption must become steadier to neutralize skepticism around sustainability. Demonstrating resilience under stress would materially support valuation. Future re‑rating depends on tightening the gap between narrative and reality.
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 19 at 9:40 AM
$BGLC Brilliant piece that captures BGLC's situation perfectly. So if you want to update your understanding of BGLC or get to know BGLC better, this is essential reading. https://beyondspx.com/quote/BGLC/analysis/bglc-s-high-risk-pivot-can-a-micro-cap-diagnostics-player-outrun-its-scale-problem-in-southeast-asia-nasdaq-bglc
1 · Reply